Literature DB >> 12421472

Activation of astrocytes by advanced glycation end products: cytokines induction and nitric oxide release.

Zhen Wang1, Dian-Dong Li, Yun-Yan Liang, Dai-Shu Wang, Nian-Sheng Cai.   

Abstract

AIM: To investigate whether two kinds of in vitro prepared advanced glycation end products (AGE), Glu-BSA and Gal-BSA, could induce proinflammatory mediators IL-1beta and TNF-alpha, as well as oxidative stress and nitric oxide (NO), in astrocytes, thus contributing to brain injury.
METHODS: Radioimmunoassay and RT-PCR technique were used to detect two cytokines' level and existence of receptor for AGE (RAGE). DTNB reaction was used to measure reduced glutathione (GSH) level. NO content was assayed using Griess reagent provided by Promega.
RESULTS: Enhanced protein levels of both cytokines in supernatants and cell lysates of astroglia cultures were detected after treated with AGE-BSA 1 g/L, especially Gal-BSA, for 72 h. The increases were also in a concentration-dependent manner. Changes in protein levels might be attributed to changes in transcriptional levels documented by semi-quantitative RT-PCR. Both AGE-BSA could also reduce astrocytic GSH and induce NO release. RAGE was detected in astrocytes.
CONCLUSION: Enhanced levels of astrocytic proinflammatory mediators IL-1beta and TNF-alpha, and oxidative stress caused by AGE might contribute to, at least partially, the detrimental effects of AGE in neuronal disorders and aging brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421472

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  13 in total

1.  Advanced glycation end products (AGEs) activate mast cells.

Authors:  E Sick; S Brehin; P André; G Coupin; Y Landry; K Takeda; J P Gies
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

2.  Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity.

Authors:  Mingwei Ni; Xin Li; Zhaobao Yin; Marta Sidoryk-Węgrzynowicz; Haiyan Jiang; Marcelo Farina; Joao B T Rocha; Tore Syversen; Michael Aschner
Journal:  Glia       Date:  2011-02-23       Impact factor: 7.452

3.  Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice.

Authors:  Michaele B Manigrasso; Piul Rabbani; Lander Egaña-Gorroño; Nosirudeen Quadri; Laura Frye; Boyan Zhou; Sergey Reverdatto; Lisa S Ramirez; Stephen Dansereau; Jinhong Pan; Huilin Li; Vivette D D'Agati; Ravichandran Ramasamy; Robert J DeVita; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Sci Transl Med       Date:  2021-11-24       Impact factor: 17.956

Review 4.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

5.  Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products.

Authors:  A Schmidt; B Kuhla; K Bigl; G Münch; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

6.  Flavonoids modulate the proliferation of Neospora caninum in glial cell primary cultures.

Authors:  Rosan Barbosa de Matos; Suzana Braga-de-Souza; Bruno Pena Seara Pitanga; Victor Diógenes Amaral da Silva; Erica Etelvina Viana de Jesus; Alexandre Morales Pinheiro; Maria de Fátima Dias Costa; Ramon dos Santos El-Bacha; Cátia Suse de Oliveira Ribeiro; Silvia Lima Costa
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

Review 7.  Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.

Authors:  Suzan Wetzels; Kristiaan Wouters; Casper G Schalkwijk; Tim Vanmierlo; Jerome J A Hendriks
Journal:  Int J Mol Sci       Date:  2017-02-15       Impact factor: 5.923

8.  Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.

Authors:  Rafael Gonzalo-Gobernado; Lucía Calatrava-Ferreras; Diana Reimers; Antonio Sánchez Herranz; Macarena Rodríguez-Serrano; Cristina Miranda; Adriano Jiménez-Escrig; Juan José Díaz-Gil; Eulalia Bazán
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

Review 9.  Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.

Authors:  Gurdip Daffu; Carmen Hurtado del Pozo; Karen M O'Shea; Radha Ananthakrishnan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Int J Mol Sci       Date:  2013-10-01       Impact factor: 5.923

10.  Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging.

Authors:  Jiahong Zhu; Xinyi Mu; Jin Zeng; Chunyan Xu; Jun Liu; Mengsi Zhang; Chengpeng Li; Jie Chen; Tinyu Li; Yaping Wang
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.